Clinical Trial Update: Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT [Phase 1]

View source ↗

Summary

Phase 1 trial exploring a calcineurin inhibitor-free graft-versus-host disease prevention regimen after related haploidentical peripheral blood stem cell transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Leukemia in Remission
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myelofibrosis
• Myelomonocytic Leukemia
• Non-hodgkin Lymphoma

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Non-Hodgkin's Lymphoma, Acute Leukemia in Remission | Phase 1 | Status: COMPLETED | Results posted: 2020-01-21